Belle Mead, NJ, United States of America

Joseph O'Sullivan

This inventor holds 10 USPTO granted patents. Top assignees: E. R. Squibb Sons, Inc., Bristol-Myers Squibb Compnay. Active years: 1985-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph O'Sullivan. Retrieved from https://idiyas.com/inventor/joseph-o-sullivan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 28(Granted Patents)

Company Filing History:

9 out of 1,624

E. R. Squibb Sons, Inc.

patents

1 out of 3,745

Bristol-Myers Squibb Compnay

patents

Years Active: 1985-1996

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5521169 - Ascosteroside and analogs thereof useful in antifungal compositions for (1996-05-28),

2. 5294725 - Scopularin (1994-03-15),

3. 5270334 - 4-methoxy-5-methyl-pyran-3-ol natural products and derivatives thereof (1993-12-14),

4. 5081225 - Gram-positive and gram-negative antibacterial compounds from the (1992-01-14),

5. 5024839 - Dactylocycline A and dactylocycline B (1991-06-18),

6. 4914245 - Culpin (1990-04-03),

7. 4904764 - 4-diazo-3-methyl-2,5-cyclohexadine-1-one and pharmacetically acceptable (1990-02-27),

8. 4754018 - Antibiotic prepared from lysobacter sp. SC 14,067 and analogs thereof (1988-06-28),

9. 4596777 - Process for preparing (3S)-3-[[[2-(protected or unprotected (1986-06-24),

10. 4537858 - Plastatin (1985-08-27),

Title: The Innovative Contributions of Joseph O'Sullivan

Introduction

Joseph O'Sullivan is a notable inventor based in Belle Mead, NJ (US). He has made significant contributions to the field of antifungal compositions and antibiotics, holding a total of 10 patents. His work has had a profound impact on the development of new treatments for fungal infections.

Latest Patents

Among his latest patents is the invention of Ascosteroside and its analogs, which are useful in antifungal compositions. This compound is obtainable by cultivating a strain of Ascotricha amphitricha A.T.C.C. No. 74237. The compounds exhibit antifungal activity and are designed for use in methods aimed at treating and preventing fungal infections. Additionally, O'Sullivan has developed Scopularin, a novel antibiotic substance prepared by cultivating a strain of the microorganism Scopulariopsis, A.T.C.C. No. 20,914. This compound, along with its alcohol derivative, has been found to possess cytochrome P450 inhibition activity.

Career Highlights

Throughout his career, Joseph O'Sullivan has worked with prominent companies such as E.R. Squibb & Sons, Inc. and Bristol-Myers Squibb Company. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

O'Sullivan has collaborated with several notable individuals in his field, including Donald R. Kirsch and Carol A. Aklonis. These partnerships have facilitated the advancement of his research and the successful development of his patented inventions.

Conclusion

Joseph O'Sullivan's innovative work in antifungal compositions and antibiotics has made a significant impact on medical science. His contributions continue to influence the development of effective treatments for fungal infections.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]